Nanosonics Withdraws Appendix 3H After Administrative Error

Nanosonics Limited ( (AU:NAN) ) just unveiled an announcement.

Nanosonics Limited has withdrawn a previously lodged Appendix 3H notification concerning the cessation of securities after identifying an administrative error in the original filing. The company has notified the market that the earlier announcement dated 1 April 2026 is being cancelled and corrected, indicating that the change is procedural in nature and not a signal of any substantive shift in its capital structure or operations.

The move underscores a focus on maintaining accurate disclosure of its issued capital to comply with ASX reporting standards. For investors and other stakeholders, the cancellation suggests that any prior inferences drawn from the original Appendix 3H should be disregarded, and that the company is seeking to rectify the record rather than announce a new corporate action affecting securities on issue.

The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.

More about Nanosonics Limited

Nanosonics Limited is a medical technology company listed on the ASX under the code NAN. The company develops and supplies infection prevention solutions for the healthcare sector, with a focus on advanced disinfection technologies for clinical environments.

Average Trading Volume: 669,898

Technical Sentiment Signal: Sell

Current Market Cap: A$1.12B

Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.